Suppr超能文献

经尿道前列腺切除术患者预防尿路感染的抗菌药物经济学分析

An economic analysis of antimicrobial prophylaxis against urinary tract infection in patients undergoing transurethral resection of the prostate.

作者信息

Liu G G, Nguyen T, Nichol M B

机构信息

Department of Pharmaceutical Economics and Policy, University of Southern California, Los Angeles 90089, USA.

出版信息

Clin Ther. 1999 Sep;21(9):1589-604. doi: 10.1016/s0149-2918(00)80013-2.

Abstract

Despite the high level of safety and low incidence of mortality associated with transurethral resection of the prostate (TURP), urinary tract infections (UTIs)-the most common complication associated with this procedure-continue to be an important source of postoperative morbidity and costs. However, there is controversy about whether antimicrobial agents should be used as UTI prophylaxis in patients undergoing TURP and, if so, which agents should be used and for what duration. This retrospective study used multivariate regression analysis to evaluate the different types and durations of antibiotic prophylaxis in 222 patients who underwent TURP at a Veterans Affairs hospital between January 1, 1995, and March 30, 1998. The primary outcome measures were total medical costs (ie, medication use, clinic office visits, and hospital care in the 4 weeks after the procedure), length of hospital stay (total days in hospital due to the procedure), and probability of UTI (incidence of infection in the 4 weeks after the procedure). Results showed that there was no difference in the length of hospital stay regardless of the regimen or duration of pre-TURP antibiotic therapy. Patients who received pre-TURP ampicillin plus ceftizoxime incurred moderately higher total medical costs than did patients who received the least costly drug, cefazolin (P = 0.10). Similarly, patients who received post-TURP quinolones incurred a significantly higher total medical cost than did patients who received co-trimoxazole (P = 0.06). We found no evidence of a relationship between use of specific parenteral or oral antibiotic prophylaxis for UTI in patients undergoing TURP and the rate of UTI in such patients. Thus there is no justification for the use of more expensive antibiotic regimens. At our institution, the preferred pre-TURP prophylactic regimen would be cefazolin, whereas co-trimoxazole would be the most cost-effective post-TURP prophylactic regimen. Because duration of post-TURP prophylaxis does not appear to influence the rate of UTI, 24 hours would seem adequate.

摘要

尽管经尿道前列腺切除术(TURP)具有较高的安全性且死亡率较低,但尿路感染(UTIs)——该手术最常见的并发症——仍然是术后发病和成本的重要来源。然而,对于接受TURP的患者是否应使用抗菌药物预防UTI,以及如果使用,应使用哪些药物以及使用多长时间,存在争议。这项回顾性研究使用多变量回归分析,评估了1995年1月1日至1998年3月30日期间在一家退伍军人事务医院接受TURP的222例患者中不同类型和持续时间的抗生素预防措施。主要结局指标包括总医疗费用(即术后4周内的药物使用、门诊就诊和住院治疗费用)、住院时间(因该手术住院的总天数)以及UTI的发生率(术后4周内的感染发生率)。结果显示,无论TURP术前抗生素治疗的方案或持续时间如何,住院时间均无差异。接受TURP术前氨苄西林加头孢唑肟治疗的患者,其总医疗费用略高于接受成本最低的药物头孢唑啉治疗的患者(P = 0.10)。同样,接受TURP术后喹诺酮类药物治疗的患者,其总医疗费用显著高于接受复方新诺明治疗的患者(P = 0.06)。我们没有发现接受TURP的患者使用特定的肠外或口服抗生素预防UTI与UTI发生率之间存在关联的证据。因此,没有理由使用更昂贵的抗生素方案。在我们机构,TURP术前首选的预防方案是头孢唑啉,而复方新诺明将是TURP术后最具成本效益的预防方案。由于TURP术后预防的持续时间似乎不影响UTI的发生率,24小时似乎就足够了。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验